Sterling Biotech Resolution Achieves INR 9,800 Crore Recovery, Delivering a Clear Win–Win Outcome
New Delhi [India], April 15: In one of the more expansive financial resolutions in recent corporate history, the Sterling Biotech matter has culminated in a substantial ₹9,800 crore recovery. Delivered...
New Delhi [India], April 15: In one of the more expansive financial resolutions in recent corporate history, the Sterling Biotech matter has culminated in a substantial ₹9,800 crore recovery. Delivered by industrialist Nitin J. Sandesara and his group, the resolution reflects a structured and comprehensive settlement, resulting in a balanced outcome for both the lending institutions and the promoters.
The genesis of the matter can be traced to an initial reference amount of ₹5,383 crore. Over the course of the proceedings, the group demonstrated a sustained approach toward financial compliance and restitution. A sum of ₹3,507 crore was directly transferred to the consortium of lenders, while an additional ₹1,192 crore was realised through established liquidation mechanisms.